Dupont Capital Management Corp Magenta Therapeutics, Inc. Transaction History

Dupont Capital Management Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 27, 2022	SELL	$2.55 - $5.23 $70,242 - $144,065	-27,546 Closed	0 $0
Q4 2021 Jan 31, 2022	SELL	$4.43 - $8.33 $48,654 - $91,488	-10,983 Reduced 28.51%	27,546 $122,000
Q3 2021 Nov 03, 2021	BUY	$6.07 - $9.89 $74,618 - $121,577	12,293 Added 46.86%	38,529 $280,000
Q2 2021 Jul 30, 2021	BUY	$9.76 - $14.15 $256,063 - $371,239	26,236 New	26,236 $257,000

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.